Brief: Alzamend Neuro Partners With Biorasi To Conduct Phase I/IIa Clinical Trial

Alzamend Neuro

04/01/2023 13:48

Jan 4 (Reuters) - Alzamend Neuro Inc  ALZN.O :
    * ALZAMEND NEURO PARTNERS WITH BIORASI TO CONDUCT A
FIRST-IN-HUMAN, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,
PARALLEL GROUP PHASE I/IIA CLINICAL TRIAL
    * ALZAMEND NEURO INC - EXPECT TO INITIATE STUDY BY END OF
MARCH
2023

Source text for Eikon:  ID:nBw95wLKRa 
Further company coverage:  ALZN.O 
 ((Reuters.Briefs@thomsonreuters.com;))